Mohammad Alyamani

Mohammad Alyamani

Cleveland Clinic - Cleveland / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4473345
person_outline Mohammad Alyamani's MOST POPULAR ARTICLES
1-) Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancerZ Li, AC Bishop, M Alyamani, JA Garcia, R Dreicer, D Bunch, J Liu, ...Nature 523 (7560), 347-351, 20152522015
2-) Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapyZ Li, M Alyamani, J Li, K Rogacki, M Abazeed, SK Upadhyay, SP Balk, ...Nature 533 (7604), 547-551, 20161482016
3-) Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancerJ Li, M Alyamani, A Zhang, KH Chang, M Berk, Z Li, Z Zhu, M Petro, ...Elife 6, e20183, 2017712017
4-) Abiraterone acetate treatment lowers 11-oxygenated androgensC Wright, P O’Day, M Alyamani, N Sharifi, RJ AuchusEuropean journal of endocrinology 182 (4), 413-421, 2020602020
5-) HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancerM Alyamani, H Emamekhoo, S Park, J Taylor, N Almassi, S Upadhyay, ...The Journal of clinical investigation 128 (8), 3333-3340, 2018512018